The effects of low-dose aspirin on preterm birth: a systematic review and meta-analysis of randomized controlled trials.
Saeed BaradwanAfaf TawfiqGhaidaa Farouk HakeemAlya AlkaffBandr HafedhYaser FadenKhalid KhadawardiSahar H AbdulghaniHanin AlthagafiAhmed Abu-ZaidPublished in: Archives of gynecology and obstetrics (2024)
LDA can significantly reduce the risk of PB < 37 and < 34 weeks. Nevertheless, further high-quality RCTs conducted in diverse populations, while accounting for potential confounding factors, are imperative to elucidate the optimal aspirin dosage, timing of initiation, and treatment duration for preventing preterm birth and to arrive at definitive conclusions.
Keyphrases
- preterm birth
- low dose
- gestational age
- low birth weight
- high dose
- antiplatelet therapy
- cardiovascular events
- heavy metals
- locally advanced
- type diabetes
- radiation therapy
- acute coronary syndrome
- squamous cell carcinoma
- coronary artery disease
- percutaneous coronary intervention
- combination therapy
- human health
- rectal cancer
- risk assessment
- atrial fibrillation